Molecular data suggest that these highly proliferative carcinoid tumors tend to have mutations (e.g., MEN1) more characteristic of typical carcinoids rather than RB1 or TP53 alterations that are typical of NECs [22]. This evidence concerns the gene TP53 and carcinoid tumor.